Back
Emerson Electric 10K Form
Buy
62
EMR
Emerson Electric
Last Price:
117.70
Seasonality Move:
4.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-08 | 10Q | EMR/Emerson Electric Quarterly |
2024-02-07 | 10Q | EMR/Emerson Electric Quarterly |
2023-11-13 | 10K | EMR/Emerson Electric Annual |
2023-08-02 | 10Q | EMR/Emerson Electric Quarterly |
2023-05-03 | 10Q | EMR/Emerson Electric Quarterly |
2023-02-08 | 10Q | EMR/Emerson Electric Quarterly |
Receive EMR News And Ratings
See the #1 stock for the next 7 days that we like better than EMR
EMR Financial Statistics
Sales & Book Value
Annual Sales: | $15.17B |
---|---|
Cash Flow: | $998M |
Price / Cash Flow: | 57.03 |
Annual Sales: | $36.36 |
Price / Book: | 3.24 |
Profitability
EPS (TTM): | 2.98000 |
---|---|
Net Income (TTM): | $1.72B |
Gross Margin: | $7.43B |
Return on Equity: | 6.45% |
Return on Assets: | 3.81% |
Emerson Electric Earnings Forecast
Key Emerson Electric Financial Ratios
- The Gross Profit Margin over the past 40 years for EMR is 48.97%.
- The Selling, General & Administrative Expenses for EMR have been equal to 27.60% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 1.97% of Operating Income.
- The Net Earning history of EMR is 87.17% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 32 years.
Emerson Electric Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Electrical Equipment |
Sector: | Industrials |
Current Symbol: | EMR |
CUSIP: | 291011 |
Website: | emerson.com |
Debt
Debt-to-Equity Ratio: | 0.49 |
---|---|
Current Ratio: | 1.16 |
Quick Ratio: | 0.67 |
Price-to-Earnings
Trailing P/E Ratio: | 5.14 |
---|---|
Forward P/E Ratio: | 18.39 |
EMR Technical Analysis vs Fundamental Analysis
Buy
62
Emerson Electric (EMR)
is a Buy
Is Emerson Electric a Buy or a Sell?
-
Emerson Electric stock is rated a Buy
The current Emerson Electric [EMR] share price is $117.67. The Score for EMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.